{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-199331","form_type":"8-K","ticker":"INO","cik":"0001055726","company_name":"INOVIO PHARMACEUTICALS, INC.","filed_at":"2024-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.041785+00:00","generated_at":"2026-05-31T09:33:53.859319+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"INOVIO enters $60M at-the-market equity distribution agreement with Oppenheimer","bullets":["Sales agreement enables INOVIO to sell up to $60M of common stock via Oppenheimer as agent.","Commission of up to 3% of gross proceeds; INOVIO may suspend or terminate offering at any time.","Shares sold under existing S-3 registration statement; proceeds for general corporate purposes.","No obligation to sell any shares; sales are at INOVIO's sole discretion and subject to market conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-199331","json":"https://secwatch.observer/filing/0001193125-24-199331.json","markdown":"https://secwatch.observer/filing/0001193125-24-199331.md","text":"https://secwatch.observer/filing/0001193125-24-199331.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1055726/000119312524199331/0001193125-24-199331-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1055726/000119312524199331/d761691d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:33:53.859319+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}